Dexamethasone in Hospitalized Patients with Covid-19

Cited by (1,035)

Items 801–900 of 1,035

1. WHO Ordinal Scale and Inflammation Risk Categories in COVID-19. Comparative Study of the Severity Scales
   Manuel Rubio‐Rivas, José María Mora‐Luján, Francesç Formiga, Coral Arévalo-Cañas, Juan Manuel Lebrón Ramos, María Victoria Villalba García, Eva Fonseca Aizpuru, Jesús Díez‐Manglano, Francisco Arnalich Fernández, Juan Luis Romero‐Cabrera et al. · 2022 · Journal of General Internal Medicine
2. SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies
   Ceri Alan Fielding, Pragati Sabberwal, James C. Williamson, Edward J. D. Greenwood, Thomas W. M. Crozier, Wioleta Milena Zelek, Jeffrey Seow, Carl Graham, Isabella Huettner, Jonathan D. Edgeworth et al. · 2022 · eLife
3. Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions
   Duvuru Geetha, Andreas Kronbichler, Megan Rutter, Divya Bajpai, Steven P. Menez, Annemarie Weißenbacher, Shuchi Anand, Eugene Lin, Nicholas Carlson, Stephen M. Sozio et al. · 2022 · Nature Reviews Nephrology
4. Pulmonary inflammation and fibroblast immunoregulation: from bench to bedside
   Mohamed Ahmed Ghonim, David F. Boyd, Tim Flerlage, Paul Glyndwr Thomas · 2023 · Journal of Clinical Investigation
5. Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individuals
   Heightman, Melissa, Prashar, Jai, Hillman, Toby E, Marks, Michael, Livingston, Rebecca, Ridsdale, Heidi A, Roy, Kay, Bell, Robert, Zandi, Michael, McNamara, Patricia et al. · 2021 · BMJ Open Respiratory Research
6. Bacterial Superinfections Among Persons With Coronavirus Disease 2019: A Comprehensive Review of Data From Postmortem Studies
   Cornelius Joseph Clancy, Ilan Steven Schwartz, Brittany Kula, M. Hong Nguyen · 2021 · Open Forum Infectious Diseases
7. Therapeutic plasma exchange in patients with life-threatening COVID-19: a randomised controlled clinical trial
   Fahad Ali Faqihi, Abdulrahman Mishaal Alharthy, Salman Abdulaziz, Abdullah Balhamar, Awad Al‐Omari, Zohair Ahmed Al Aseri, Hani Tamim, Saleh A. Alqahtani, Demetrios James Kutsogiannis, Peter George Brindley et al. · 2021 · International Journal of Antimicrobial Agents
8. Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications
   Adekunle Babajide Rowaiye, Okiemute Ajiroghene Okpalefe, Olukemi Adejoke Onuh, Joyce Oloaigbe Ogidigo, Oluwakemi Hannah Oladipo, Amoge Chidinma Ogu, Angus Nnamdi Oli, Samson Ayodeji Olofinsae, Onyekachi Onyekwere, Abdullahi Rabiu Abubakar et al. · 2021 · Journal of Inflammation Research
9. Races of small molecule clinical trials for the treatment of COVID‐19: An up‐to‐date comprehensive review
   Suwen Hu, Songwei Jiang, Qi Xiang, Renren Bai, Xiang‐Yang Ye, Tian Xie · 2021 · Drug Development Research
10. Development of a multiomics model for identification of predictive biomarkers for COVID-19 severity: a retrospective cohort study
    Seul Kee Byeon, Anil Kumar Madugundu, Kishore Garapati, Madan Gopal Ramarajan, Mayank Saraswat, Praveen M Kumar, Travis K. Hughes, Rameen Shah, Mrinal M. Patnaik, Nicholas Chia et al. · 2022 · The Lancet Digital Health
11. Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of April 26, 2021
    Robert Flisiak, Andrzej Horban, Jerzy Jaroszewicz, Dorota Kozielewicz, Agnieszka Mastalerz–Migas, Radosław Owczuk, Miłosz Parczewski, Małgorzata Pawłowska, Anna Piekarska, Krzysztof Adam Simon et al. · 2021 · Polskie Archiwum Medycyny Wewnętrznej
12. Presence of hyaluronan in lung alveoli in severe Covid-19: An opening for new treatment options?
    Urban Hellman, Mats G. Karlsson, Anna Engström‐Laurent, Sara Cajander, Luiza Dorofte, Clas Ahlm, Claude Laurent, Anders Blomberg · 2020 · Journal of Biological Chemistry
13. The prognostic value of the SOFA score in patients with COVID-19
    Zheng Yang, Qinming Hu, Fei Huang, Shouxin Xiong, Yi Sun · 2021 · Medicine
14. Post-discharge critical COVID-19 lung function related to severity of radiologic lung involvement at admission
    Laurent Truffaut, Lucas Demey, Anne-Violette Bruyneel, Alain Roman, Stéphane Alard, Nathalie De Vos, Marie Bruyneel · 2021 · Respiratory Research
15. Misleading clinical evidence and systematic reviews on ivermectin for COVID-19
    Luis Garegnani, Eva Madrid A, Nicolás Meza · 2021 · BMJ Evidence-Based Medicine
16. Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective
    Charis Wong, Maria Stavrou, Elizabeth Elliott, Jenna M. Gregory, Nigel P. Leigh, Ashwin Arnold Pinto, Timothy L. Williams, Jeremy Chataway, Robert J Swingler, Mahesh Parmar et al. · 2021 · Brain Communications
17. Dexamethasone in hospitalised COVID-19 patients not on intensive respiratory support
    Kristina A. Crothers, Rian DeFaccio, Janet Tate, Patrick R. Alba, Matthew Bidwell Goetz, Barbara Ellen Jones, Joseph T. King, Vincent C. Marconi, Michael Ohl, Christopher T. Rentsch et al. · 2021 · European Respiratory Journal
18. Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection
    Ruben J. Mylvaganam, Joseph Isaac Bailey, Jacob Iasha Sznajder, Marc A. Sala · 2021 · European Respiratory Review
19. How to Use and Interpret the Results of a Platform Trial
    Jay Park, Michelle A. Detry, Srinivas Murthy, Gordon Henry Guyatt, Edward J. Mills · 2022 · JAMA
20. Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates
    Liliana A. Rodrigues, Renata Bento Cunha, Tatiana D. Vassilevskaia, Miguel Viveiros, Celso Vladimiro Cunha · 2022 · Molecules
21. Risk factors for COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis
    Francesca Gioia, Laura Naëmi Walti, Ani Orchanian‐Cheff, Shahid Husain · 2024 · The Lancet Respiratory Medicine
22. The “Infodemic” of COVID‐19
    Daniel H. Solomon, Richard Bucala, Mariana J. Kaplan, Peter Andrija Nigrovic · 2020 · Arthritis & Rheumatology
23. Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients
    Sandra Jonmarker, Jacob Hollenberg, Martin J.A. Dahlberg, Otto Stackelberg, Jacob Litorell, Asa Hallqvist Everhov, Hans Järnbert‐Pettersson, Mårten Söderberg, Jonathan Grip, Anna Regina Schandl et al. · 2020 · Critical Care
24. An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come?
    Omkar Indari, Shweta Jakhmola, Elangovan Manivannan, Hem Chandra Jha · 2021 · Frontiers in Pharmacology
25. Beware of Steroid-Induced Avascular Necrosis of the Femoral Head in the Treatment of COVID-19—Experience and Lessons from the SARS Epidemic
    Shenqi Zhang, Chengbin Wang, Lei Shi, Qingyun Xue · 2021 · Drug Design Development and Therapy
26. Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study
    Thomas Benfield, Jacob Bodilsen, Christian Brieghel, Zitta Barrella Harboe, Marie Helleberg, Claire Præst Holm, Simone Bastrup Israelsen, Janne Jensen, Tomas Østergaard Jensen, Işık Somuncu Johansen et al. · 2021 · Clinical Infectious Diseases
27. Serum Complement C3 and C4 and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression
    Angelo Zinellu, Arduino Aleksander Mangoni · 2021 · Frontiers in Immunology
28. Attenuation of clinical and immunological outcomes during SARS‐CoV‐2 infection by ivermectin
    Guilherme Dias de Melo, Françoise Lazarini, Florence Larrous, Lena Feige, Étienne Kornobis, Sylvain Levallois, Agnès Marchio, Lauriane Kergoat, David Hardy, Thomas Cokelaer et al. · 2021 · EMBO Molecular Medicine
29. Vitamin C and COVID-19 treatment: A systematic review and meta-analysis of randomized controlled trials
    Dimple Rawat, Avishek Roy, Souvik Maitra, Arti Gulati, Puneet Khanna, Dalim Kumar Baidya · 2021 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
30. Why Females Do Better: The X Chromosomal TLR7 Gene-Dose Effect in COVID-19
    Anna E. Spiering, Teun J. de Vries · 2021 · Frontiers in Immunology
31. Oral antiviral treatments for COVID-19: opportunities and challenges
    Laila Rahmah, Sunny Okechukwu Abarikwu, Amanuel Godana Arero, Mickael Essouma, Aliyu Tijani Jibril, Andrzej Fal, Robert Flisiak, Rangarirai Makuku, Leander Penaso Marquez, Kawthar Mohamed et al. · 2022 · Pharmacological Reports
32. Nonrelapse mortality after CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry
    Jean Lemoine, Emmanuel Bachy, Guillaume Cartron, David Beauvais, Thomas Gastinne, Roberta Di Blasi, Marie‐Thérèse Rubio, Stéphanie Guidez, Mohamad Mohty, Olivier Casasnovas et al. · 2023 · Blood Advances
33. Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
    Sophie Juul, Emil Eik Nielsen, Joshua Buron Feinberg, Faiza Siddiqui, Caroline Barkholt Kamp, Emily Barot, Niklas Nielsen, Peter Bentzer, Areti Angeliki Veroniki, Lehana Thabane et al. · 2020 · PLoS Medicine
34. Comparative Survival Analysis of Immunomodulatory Therapy for Coronavirus Disease 2019 Cytokine Storm
    Sonali Narain, Dimitre G. Stefanov, Alice S. Chau, Andrew G. Weber, Galina S. Marder, Blanka M. Kaplan, Prashant Malhotra, Ona Bloom, Audrey Liu, MARTIN L. LESSER et al. · 2020 · CHEST Journal
35. Haemophagocytic syndrome and COVID-19
    Soledad Retamozo, Pilar Brito‐Zerón, Antoni Sisó‐Almirall, Alejandra Flores-Chávez, M.J. Soto Cárdenas, Manuel Ramos‐Casals · 2021 · Clinical Rheumatology
36. Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis
    Radha Gopalaswamy, Selvakumar Subbian · 2021 · International Journal of Molecular Sciences
37. Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses
    Ali Ahmed Rabaan, Shamsah H. Al-Ahmed, Mohammed Ahmed Garout, Ayman M. Al‐Qaaneh, Anupam Ashutosh Sule, Raghavendra Tirupathi, Abbas Saleh Al Mutair, Saad Alhumaid, Abdulkarim Hasan, Manish K. Dhawan et al. · 2021 · Pathogens
38. Distinctive features of severe SARS-CoV-2 pneumonia
    G. R. Scott Budinger, Alexander V. Misharin, Karen M. Ridge, Benjamin David Singer, Richard G. Wunderink · 2021 · Journal of Clinical Investigation
39. D‐dimer, CRP, PCT, and IL‐6 Levels at Admission to ICU Can Predict In‐Hospital Mortality in Patients with COVID‐19 Pneumonia
    Marija Milenković, Adi Hadžibegović, Mirjana K. Kovac, Bojan Jovanović, Jovana Stanisavljević, Marina Djikic, Djuro Šijan, Nebojsa Gojko Ladjevic, Ivan Palibrk, Marija Djukanović et al. · 2022 · Oxidative Medicine and Cellular Longevity
40. COVID-19 and kidney disease: insights from epidemiology to inform clinical practice
    Viyaasan Mahalingasivam, Guobin Su, Masao Iwagami, Mogamat Razeen Davids, James B. Wetmore, Dorothea Nitsch · 2022 · Nature Reviews Nephrology
41. Assessment of Awake Prone Positioning in Hospitalized Adults With COVID-19
    Edward T. Qian, Cheryl L. Gatto, Olga Amusina, Mary Lynn Dear, William Hiser, Reagan B. Buie, Sunil B. Kripalani, Frank E. Harrell, Robert Edward Freundlich, Yue Gao et al. · 2022 · JAMA Internal Medicine
42. COVID-19 disease and immune dysregulation
    Ethan Davitt, Colin Davitt, Monty B. Mazer, Sathya Sri Areti, Richard S. Hotchkiss, Kenneth E. Remy · 2022 · Best Practice & Research Clinical Haematology
43. Cognitive dysfunction in post‐COVID‐19 condition: Mechanisms, management, and rehabilitation
    Marika Christina Möller, Kristian Borg, Christer Janson, Maria Lerm, Johan Normark, Katarina Niward · 2023 · Journal of Internal Medicine
44. Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy
    Vincenzo Montesarchio, Roberto Parrella, Chiara Iommelli, Antonella Bianco, Elio Manzillo, Fiorentino Fraganza, Cristiana Palumbo, Gaetano Rea, Patrizia Murino, Rosanna Carmela De Rosa et al. · 2020 · Journal for ImmunoTherapy of Cancer
45. Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies
    Praveen Mathews Varghese, Anthony George Tsolaki, Hadida Yasmin, Abhishek Shastri, Janez Ferluga, Manu Vatish, Taruna Madan, Uday Kishore · 2020 · Immunobiology
46. Multisystem Inflammatory Syndrome in Children: Survey of Protocols for Early Hospital Evaluation and Management
    Matthew L. Dove, Preeti Jaggi, Michael Scott Kelleman, Mayssa M. Abuali, Jocelyn Y. Ang, Wassim M. Ballan, Sanmit K. Basu, Michael Jay Campbell, Sathish Mallenahalli Chikkabyrappa, Nadine F. Choueiter et al. · 2020 · The Journal of Pediatrics
47. COVID-19 in Brazil: 150,000 deaths and the Brazilian underreporting
    Tatiana Aline Carvalho, Matheus Negri Boschiero, Fernando Augusto Lima Marson · 2020 · Diagnostic Microbiology and Infectious Disease
48. Can Melatonin Be a Potential “Silver Bullet” in Treating COVID-19 Patients?
    Daniel Pedro Cardinali, Gregory M. Brown, Seithikurippu Ratnas Pandi-Perumal · 2020 · Diseases
49. Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)
    Peter Andrew McCullough, Paul Elias Alexander, Robin Armstrong, Cristian Arvinte, A. Bain, Richard P. Bartlett, Robert L. Berkowitz, Andrew C. Berry, Thomas Julius Borody, Joseph Brewer et al. · 2020 · Reviews in Cardiovascular Medicine
50. COVID-19 and cytokine storm syndrome: are there lessons from macrophage activation syndrome?
    Michael J. Ombrello, Grant S. Schulert · 2021 · Translational research
51. Vitamin A Plasma Levels in COVID-19 Patients: A Prospective Multicenter Study and Hypothesis
    Phil‐Robin Tepasse, Richard Vollenberg, Manfred Fobker, Iyad Kabar, Hartmut Schmidt, Jörn Arne Meier, Tobias Max Nowacki, Anna Hüsing‐Kabar · 2021 · Nutrients
52. Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis
    Woon Hean Chong, Biplab Kumar Saha, Kristoffer Neu · 2021 · Infection
53. Ventilator-associated pneumonia among SARS-CoV-2 acute respiratory distress syndrome patients
    Jacopo Fumagalli, Mauro Panigada, Michael Klompas, Lorenzo M. Berra · 2021 · Current Opinion in Critical Care
54. A global picture: therapeutic perspectives for COVID-19
    V. Chavda, C. Kapadia, Shailvi Soni, R. Prajapati, S. Chauhan, M. Yallapu, V. Apostolopoulos · 2022 · Immunotherapy
55. SARS-CoV-2-triggered mast cell rapid degranulation induces alveolar epithelial inflammation and lung injury
    Mengli Wu, Feng‐Liang Liu, Jing Sun, Xin Li, Xiao-Yan He, Hong‐Yi Zheng, Rongjuan Pei, Hao Sun, Yan-Heng Zhou, Qihong Yan et al. · 2021 · Signal Transduction and Targeted Therapy
56. Perinatal SARS-CoV-2 Infection and Neonatal COVID-19: A 2021 Update
    Deepika Sankaran, Natasha A. Nakra, Ritu Cheema, Dean A. Blumberg, Satyan Lakshminrusimha · 2021 · NeoReviews
57. A multisystem, cardio-renal investigation of post-COVID-19 illness
    Andrew Morrow, Robert Sykes, Alasdair McIntosh, Anna L. Kamdar, Catherine N. Bagot, Hannah Kelly Bayes, Kevin G. Blyth, Michael Briscoe, Heerajnarain Bulluck, David Carrick et al. · 2022 · Nature Medicine
58. COVID-19 drug discovery and treatment options
    Jasper Fuk‐Woo Chan, Shuofeng Yuan, Hin Chu, Siddharth Sridhar, Kwok‐Yung Yuen · 2024 · Nature Reviews Microbiology
59. Influenza and RSV incidence during COVID-19 pandemic—an observational study from in-hospital point-of-care testing
    Stamm, Paul, Sagoschen, Ingo, Weise, Kerstin, Plachter, Bodo, Münzel, Thomas, Gori, Tommaso, Vosseler, Markus · 2021 · Medical Microbiology and Immunology
60. COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers
    Malin L. Hultcrantz, Joshua Ryan Richter, Cara Ann Rosenbaum, Dhwani Patel, Eric L. Smith, Neha Korde, Sydney X. Lu, Sham Mailankody, Urvi Ashok Shah, Alexander M. Lesokhin et al. · 2020 · Blood Cancer Discovery
61. Current state of vaccine development and targeted therapies for COVID-19: impact of basic science discoveries
    Ali J. Marian · 2020 · Cardiovascular Pathology
62. Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies
    Behnood Bikdeli, Azita H. Talasaz, Farid Rashidi, Babak Sharif-Kashani, Mohsen Farrokhpour, Hooman Bakhshandeh, Seyed Hashem Sezavar, Ali Dabbagh, Mohammad Taghi Beigmohammadi, Pooya Payandemehr et al. · 2020 · Thrombosis Research
63. Nature and Dimensions of Systemic Hyperinflammation and its Attenuation by Convalescent Plasma in Severe COVID-19
    Purbita Bandopadhyay, Ranit D’Rozario, Abhishake Lahiri, Jafar Sarif, Yogiraj Ray, Shekhar Ranjan Paul, Rammohan Roy, Rajshekhar Maiti, Kausik Chaudhuri, Saugata Bagchi et al. · 2021 · The Journal of Infectious Diseases
64. COVID-19-associated Aspergillus tracheobronchitis: the interplay between viral tropism, host defence, and fungal invasion
    Frank L. van de Veerdonk, Roger J. M. Brüggemann, Shoko Vos, Gert D. Hertogh, Joost Wauters, Monique H E Reijers, Mihai Gheorghe Netea, Jeroen A. Schouten, Paul E. Verweij · 2021 · The Lancet Respiratory Medicine
65. Myocarditis associated with Covid‐19 disease: A systematic review of published case reports and case series
    Sawai Singh Rathore, Gianpier Alonzo Rojas, Manush Sondhi, Suveenkrishna Pothuru, Reshma Pydi, Neeraj Kancherla, Romil Singh, Noman Khurshid Ahmed, Jill Shah, Sohaib Tousif et al. · 2021 · International Journal of Clinical Practice
66. SARS-CoV-2 Infection and Associated Cardiovascular Manifestations and Complications in Children and Young Adults: A Scientific Statement From the American Heart Association
    Pei-Ni Jone, Anitha John, Matthew E. Oster, Kiona Allen, Adrianna H. Tremoulet, Elizabeth V. Saarel, Linda M. Lambert, Shelley D. Miyamoto, Sarah D. de Ferranti · 2022 · Circulation
67. Pandemics and maternal health: the indirect effects of COVID‐19
    Lucas, D. N., Bamber, J. H. · 2021 · Anaesthesia
68. Four months into the COVID-19 pandemic, Sweden’s prized herd immunity is nowhere in sight
    Eric J W Orlowski, David J.A. Goldsmith · 2020 · Journal of the Royal Society of Medicine
69. A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2
    Alexander Simonis, Sebastian Julian Theobald, Gerd Fätkenheuer, Jan Rybniker, Jakob J Malin · 2020 · EMBO Molecular Medicine
70. COVID-19 and the kidney
    Mohamed Hassanein, Yeshwanter Radhakrishnan, John R. Sedor, Tushar J. Vachharajani, Vidula Vachharajani, Joshua J. Augustine, Sevag G. Demirjian, George Thomas · 2020 · Cleveland Clinic Journal of Medicine
71. Interferon Beta-1b and Lopinavir–Ritonavir for Middle East Respiratory Syndrome
    Yaseen M. Arabi, Ayed Y. Asiri, Abdullah Mufareh Assiri, Hanan H. Balkhy, Ali A. A. Al bshabshe, Majed Al Jeraisy, Yasser Mandourah, Mohamed H. Azzam, Abdulhadi M. Bin Eshaq, Sameera Al Johani et al. · 2020 · New England Journal of Medicine
72. Hospitalised COVID-19 patients of the Mount Sinai Health System: a retrospective observational study using the electronic medical records
    Zichen Wang, Amanda B. Zheutlin, Yu-Han Kao, Kristin L. Ayers, Susan J. Gross, Patricia Kovatch, Sharon Nirenberg, Alexander W. Charney, Girish N. Nadkarni, Jessica K. De Freitas et al. · 2020 · BMJ Open
73. Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis
    Alejandro Piscoya, Luis Fernando Ng-Sueng, Angela Parra del Riego, Renato Cerna-Viacava, Vinay Pasupuleti, Yuani M. Roman, Priyaleela Thota, Charles Michael White, Adrián Vladimir Hernández · 2020 · PLoS ONE
74. Unraveling the mechanism of arbidol binding and inhibition of SARS-CoV-2: Insights from atomistic simulations
    Aditya Kumar Padhi, Aniruddha Seal, Javed Masood Khan, Maqusood Ahamed, Timir Tripathi · 2020 · European Journal of Pharmacology
75. Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro
    Finny S. Varghese, Esther van Woudenbergh, Gijs J. Overheul, Marc J. Eleveld, Lisa Kurver, Niels van Heerbeek, Arjan van Laarhoven, Pascal Miesen, Gerco den Hartog, Marien Isaäk de Jonge et al. · 2021 · Viruses
76. Major Update: Remdesivir for Adults With COVID-19
    Anjum S. Kaka, Roderick H. MacDonald, Nancy L. Greer, Kathryn Vela, Wei Duan‐Porter, Adam J. Obley, Timothy J Wilt · 2021 · Annals of Internal Medicine
77. Clinical profile of hospitalized COVID-19 patients in first & second wave of the pandemic
    Gunjan Kumar, Aparna Mukherjee, RAVENDRA KUMAR SHARMA, Geetha R. Menon, Damodar Sahu, Naveet Wig, Samiran Panda, Vishnu Vardhan Rao, Sujeet Kumar Singh, Randeep Guleria et al. · 2021 · The Indian Journal of Medical Research
78. Potential Adverse Effects of Dexamethasone Therapy on COVID-19 Patients: Review and Recommendations
    Fei Chen, Lanting Hao, Shiheng Zhu, Xinyuan Yang, Wenhao Shi, Kai Zheng, Tenger Wang, Huiran Chen · 2021 · Infectious Diseases and Therapy
79. Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients
    Emma J. Kooistra, Miranda van Berkel, N. Kempen, Celine R. M. van Latum, Niklas Bruse, Tim Frenzel, Maarten J. W. van den Berg, Jeroen A. Schouten, Matthijs Kox, Peter Pickkers · 2021 · Critical Care
80. Recent advances in management of COVID-19: A review
    Soraya Mouffak, Qamar Shubbar, Ekram Saleh, Raafat El‐Awady · 2021 · Biomedicine & Pharmacotherapy
81. Melatonin effects on sleep quality and outcomes of COVID‐19 patients: An open‐label, randomized, controlled trial
    Seyed Abbas Mousavi, Keyvan Heydari, Hossein Mehravaran, Majid Saeedi, Reza Alizadeh‐Navaei, Akbar Hedayatizadeh‐Omran, Amir Shamshirian · 2021 · Journal of Medical Virology
82. The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication
    Qin Ning, Di Wu, Xiaojing Wang, Dong Xi, Tao Chen, Guang Chen, Hongwu Wang, Huiling Lü, Ming Wang, Lin Zhu et al. · 2022 · Signal Transduction and Targeted Therapy
83. COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records
    Johan H. Thygesen, Christopher Tomlinson, Sam Hollings, Mehrdad A. Mizani, Álex Handy, Ashley Akbari, Amitava Banerjee, Jennifer Cooper, Alvina Grace Lai, Kezhi Li et al. · 2022 · The Lancet Digital Health
84. Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection
    Peiran Chen, Mandi Wu, Yaqing He, Bing‐Hua Jiang, Ming‐Liang He · 2023 · Signal Transduction and Targeted Therapy
85. Let fever do its job
    Sylwia Wrotek, Edmund Kenwood LeGrand, Artur Dzialuk, Joe Alcock · 2020 · Evolution Medicine and Public Health
86. Biocatalytic routes to anti-viral agents and their synthetic intermediates
    Sjoerd Slagman, Wolf‐Dieter Fessner · 2020 · Chemical Society Reviews
87. Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression
    André F. Rendeiro, Joseph Casano, Charles Kyriakos Vorkas, Harjot Kaur Singh, Ayana E. Morales, Robert Andrew Desimone, Grant B. Ellsworth, Rosemary Soave, Shashi N. Kapadia, Kohta Saito et al. · 2020 · Life Science Alliance
88. Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia
    Nicolas de Prost, Paul Bastard, Romain Arrestier, Slim Fourati, Mathieu Mahévas, Sonia Burrel, Karim Dorgham, Guy Gorochov, Yacine Tandjaoui-Lambiotte, Imane Azzaoui et al. · 2021 · Journal of Clinical Immunology
89. Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-blind, Randomized, Controlled Clinical Trial
    Leila Shahbaznejad, Alireza Davoudi, Gohar Eslami, John Seth Markowitz, Mohammad Reza Navaeifar, Fatemeh Hosseinzadeh, Faeze Sadat Movahedi, Mohammad Sadegh Rezai · 2021 · Clinical Therapeutics
90. Tocilizumab treatment for COVID-19 patients: a systematic review and meta-analysis
    Qiu Wei, Lin Hua, Rongguo Wei, Nian Chen, Fan He, Dong-Hua Zou, Jinru Wei · 2021 · Infectious Diseases of Poverty
91. Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis
    Giuseppe Fiorentino, Antonietta Coppola, Raffaele Izzo, Anna Annunziata, Mariano Bernardo, Angela Lombardi, Valentina Trimarco, Gaetano Santulli, Bruno Trimarco · 2021 · EClinicalMedicine
92. Predictive ability of severity scores and outcomes for mortality in kidney transplant recipients with coronavirus disease 2019 admitted to the intensive care unit: results from a Brazilian single-center cohort study
    Maria Bethânia Peruzzo, Lúcio Requião‐Moura, Mônica Rica Nakamura, Laila Almeida Viana, Marina Pontello Cristelli, Helio Tedesco Silva Junior, Jose Osmar Medina-Pestana · 2022 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
93. Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
    Thomas Marjot, Christiane Sigrid Eberhardt, Tobias Boettler, Luca Saverio Belli, Marina Berenguer, Marı́a Buti, Rajiv Jalan, Mario Umberto Mondelli, Richard Moreau, Daniel Shouval et al. · 2022 · Journal of Hepatology
94. Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents
    Norberto Perico, Monica Cortinovis, Fredy Suter, Giuseppe Remuzzi · 2022 · The Lancet Infectious Diseases
95. Post-COVID-19 pulmonary fibrosis: An ongoing concern
    Nuha Nasser Alrajhi · 2023 · Annals of Thoracic Medicine
96. Comprehensive Review on Current Interventions, Diagnostics, and Nanotechnology Perspectives against SARS-CoV-2
    Deepak Singh Chauhan, Rajendra Prasad, Rohit Srivastava, Meena Jaggi, Subhash C. Chauhan, Murali Mohan Yallapu · 2020 · Bioconjugate Chemistry
97. Colchicine to Weather the Cytokine Storm in Hospitalized Patients with COVID-19
    Luigi Brunetti, Oumou Diawara, Andrew Tsai, Bonnie L. Firestein, Ronald Nahass, George J. Poiani, Naomi Schlesinger · 2020 · Journal of Clinical Medicine
98. COVID-19—Lessons Learned and Questions Remaining
    Ferric C. Fang, Constance Ann Benson, Carlos del Rı́o, Kathryn M. Edwards, Vance G. Fowler, David N. Fredricks, Ajit P. Limaye, Barbara E. Murray, Susanna Naggie, Peter G. Pappas et al. · 2020 · Clinical Infectious Diseases
99. Repurposing drugs for the management of COVID-19
    Jacopo Cusinato, Ylenia Cau, Anna Maria Calvani, Mattia Mori · 2020 · Expert Opinion on Therapeutic Patents
100. Manipulation of ACE2 expression in COVID-19
     Farhan Chaudhry, Sergio Lavandero, Xiang Xie, Basera Sabharwal, Ying‐Ying Zheng, Ashish Adrian Correa, Jagat Narula, Phillip David Levy · 2020 · Open Heart